[시장보고서]최소침습 생검 기술 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제공 제품별, 기술별, 순환 바이오마커별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

최소침습 생검 기술 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제공 제품별, 기술별, 순환 바이오마커별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

Minimally Invasive Biopsy Techniques Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Offered, By Technique, By Circulating Biomarker, By Application, By End User, By Region, By Competition, 2020-2030F

상품코드 : 1878818

리서치사 : TechSci Research

발행일 : 2025년 11월

페이지 정보 : 영문 185 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,681,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 8,165,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 11,877,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 최소침습 생검 기술 시장은 2024년에 137억 5,000만 달러로 평가되었으며, 2030년까지 CAGR 10.30%로 성장하여 247억 6,000만 달러에 달할 것으로 예측됩니다.

최소침습적 생검 기술은 기존의 외과적 생검에 비해 신체적 부담이 적고, 회복 기간이 짧으며, 합병증 위험을 줄일 수 있도록 설계된 조직 또는 체액 샘플 채취를 위한 진단 절차를 말합니다. 이 시장의 성장을 이끄는 주요 요인으로는 확정적인 조직 진단이 필요한 암 및 기타 질환의 전 세계 유병률 증가, 최소침습적 의료 개입에 대한 환자들의 선호도 증가, 영상 지침 및 장비 정확도의 지속적인 기술 발전 등이 있습니다. 이러한 혁신은 샘플 채취의 정확성과 효율성을 향상시켜 보다 광범위한 임상 적용을 지원합니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	137억 5,000만 달러
시장 규모 : 2030년	247억 6,000만 달러
CAGR : 2025-2030년	10.3%
가장 빠르게 성장하는 부문	액체 생검
최대 시장	북미

주요 시장 촉진요인

주요 시장 과제

주요 시장 동향

시장 규모 및 예측
- 금액별
시장 점유율과 예측
- 제공 제품별(검사, 키트·소모품, 기기)
- 기술별(액체 생검, 광학 생검, 브러시 생검, 색소성 병변 검사, 기타)
- 순환 바이오마커별(순환종양세포(CTCs), 세포 유리 DNA(cfDNA), 순환 종양 DNA(ctDNA), 세포외소포, 기타)
- 용도별(임상, 치료)
- 최종사용자별(병원·진료소, 외래 진료 센터, 학술·조사기관)
- 지역별
- 기업별(2024)
시장 맵

제6장 북미의 최소침습 생검 기술 시장 전망

시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
- 미국
- 캐나다
- 멕시코

제7장 유럽의 최소침습 생검 기술 시장 전망

시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인

제8장 아시아태평양의 최소침습 생검 기술 시장 전망

시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
- 중국
- 인도
- 일본
- 한국
- 호주

제9장 중동 및 아프리카의 최소침습 생검 기술 시장 전망

시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
- 사우디아라비아
- 아랍에미리트
- 남아프리카공화국

제10장 남미의 최소침습 생검 기술 시장 전망

시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
- 브라질
- 콜롬비아
- 아르헨티나

제11장 시장 역학

성장 촉진요인
과제

제12장 시장 동향과 발전

인수합병
제품 출시
최근 동향

제13장 세계의 최소침습 생검 기술 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협

제15장 경쟁 구도

F. Hoffmann-La Roche AG
Thermo Fisher Scientific, Inc.
PerkinElmer Inc.
QIAGEN NV
Guardant Health, Inc.
Veracyte, Inc.
Myriad Genetics, Inc.
Biocept, Inc.
NeoGenomics Laboratories, Inc.
Adaptive Biotechnologies Corporation

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

KSM

영문 목차

영문목차

The Global Minimally Invasive Biopsy Techniques Market, valued at USD 13.75 Billion in 2024, is projected to experience a CAGR of 10.30% to reach USD 24.76 Billion by 2030. Minimally invasive biopsy techniques involve diagnostic procedures designed to obtain tissue or fluid samples with reduced physical trauma, shorter recovery times, and decreased complication risks compared to conventional surgical biopsies. Key drivers propelling this market's growth include the rising global prevalence of cancer and other conditions necessitating definitive tissue diagnosis, an increasing patient inclination towards less invasive medical interventions, and continuous technological advancements in imaging guidance and device precision. These innovations enhance the accuracy and efficiency of sample collection, supporting broader clinical

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 13.75 Billion
Market Size 2030	USD 24.76 Billion
CAGR 2025-2030	10.3%
Fastest Growing Segment	Liquid Biopsy
Largest Market	North America

Key Market Drivers

The increasing global burden of cancer and chronic diseases stands as a primary catalyst for the expansion of the minimally invasive biopsy techniques market. As diagnostic needs escalate for a growing patient population, the imperative for accurate and timely tissue sampling intensifies. These techniques offer a less intrusive yet highly effective method for obtaining critical diagnostic information, directly responding to the rising disease prevalence. According to the World Health Organization (WHO), on February 1, 2024, in "Global cancer burden growing, amidst mounting need for services," there were an estimated 20 million new cancer cases globally in 2022, underscoring the vast and continuous demand for robust diagnostic interventions. This widespread incidence drives healthcare systems to prioritize efficient and patient-friendly diagnostic pathways.

Key Market Challenges

The inherent technical complexity and demanding learning curve associated with specialized minimally invasive biopsy procedures represent a significant challenge to the growth of the Global Minimally Invasive Biopsy Techniques Market. These procedures require extensive training and substantial expertise from healthcare professionals to ensure optimal diagnostic yield and patient safety. This stringent requirement limits the number of practitioners qualified to perform these advanced techniques, directly impeding broader clinical adoption.

Key Market Trends

Liquid biopsy dominance and expansion represents a pivotal trend reshaping cancer diagnostics by offering minimally invasive methods for disease detection and surveillance. These blood-based tests analyze circulating tumor DNA and other biomarkers, providing a less intrusive alternative to conventional tissue biopsies, especially beneficial for inaccessible tumors or for continuous monitoring of treatment efficacy. The Association for Molecular Pathology and the College of American Pathologists collectively published 13 best practice recommendations for validating and reporting clinical circulating tumor DNA assays, indicating a growing formalization and clinical acceptance of these techniques in October 2023. This advancement facilitates earlier detection of recurrence and precise assessment of therapeutic response.

Key Market Players

F. Hoffmann-La Roche AG
Thermo Fisher Scientific, Inc.
PerkinElmer Inc.
QIAGEN NV
Guardant Health, Inc.
Veracyte, Inc.
Myriad Genetics, Inc.
Biocept, Inc.
NeoGenomics Laboratories, Inc.
Adaptive Biotechnologies Corporation

Report Scope:

In this report, the Global Minimally Invasive Biopsy Techniques Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Minimally Invasive Biopsy Techniques Market, By Product Offered:

Tests
Kits & Consumables
Instruments

Minimally Invasive Biopsy Techniques Market, By Technique:

Liquid Biopsy
Optical Biopsy
Brush Biopsy
Pigmented Lesion Assays
Others

Minimally Invasive Biopsy Techniques Market, By Circulating Biomarker:

Circulating Tumor Cells (CTCs)
Cell Free DNA (cfDNA)
Circulating Tumor DNA (ctDNA)
Extracellular Vesicles
Others

Minimally Invasive Biopsy Techniques Market, By Application:

Clinical
Therapeutic

Minimally Invasive Biopsy Techniques Market, By End User:

Hospitals & Clinics
Ambulatory Care Center
Academic & Research Institutions

Minimally Invasive Biopsy Techniques Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Minimally Invasive Biopsy Techniques Market.

Available Customizations:

Global Minimally Invasive Biopsy Techniques Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Minimally Invasive Biopsy Techniques Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product Offered (Tests, Kits & Consumables, Instruments)
- 5.2.2. By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, Others)
- 5.2.3. By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, Others)
- 5.2.4. By Application (Clinical, Therapeutic)
- 5.2.5. By End User (Hospitals & Clinics, Ambulatory Care Center, Academic & Research Institutions)
- 5.2.6. By Region
- 5.2.7. By Company (2024)
5.3. Market Map

6. North America Minimally Invasive Biopsy Techniques Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product Offered
- 6.2.2. By Technique
- 6.2.3. By Circulating Biomarker
- 6.2.4. By Application
- 6.2.5. By End User
- 6.2.6. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Minimally Invasive Biopsy Techniques Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product Offered
    - 6.3.1.2.2. By Technique
    - 6.3.1.2.3. By Circulating Biomarker
    - 6.3.1.2.4. By Application
    - 6.3.1.2.5. By End User
- 6.3.2. Canada Minimally Invasive Biopsy Techniques Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product Offered
    - 6.3.2.2.2. By Technique
    - 6.3.2.2.3. By Circulating Biomarker
    - 6.3.2.2.4. By Application
    - 6.3.2.2.5. By End User
- 6.3.3. Mexico Minimally Invasive Biopsy Techniques Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product Offered
    - 6.3.3.2.2. By Technique
    - 6.3.3.2.3. By Circulating Biomarker
    - 6.3.3.2.4. By Application
    - 6.3.3.2.5. By End User

7. Europe Minimally Invasive Biopsy Techniques Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product Offered
- 7.2.2. By Technique
- 7.2.3. By Circulating Biomarker
- 7.2.4. By Application
- 7.2.5. By End User
- 7.2.6. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Minimally Invasive Biopsy Techniques Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product Offered
    - 7.3.1.2.2. By Technique
    - 7.3.1.2.3. By Circulating Biomarker
    - 7.3.1.2.4. By Application
    - 7.3.1.2.5. By End User
- 7.3.2. France Minimally Invasive Biopsy Techniques Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product Offered
    - 7.3.2.2.2. By Technique
    - 7.3.2.2.3. By Circulating Biomarker
    - 7.3.2.2.4. By Application
    - 7.3.2.2.5. By End User
- 7.3.3. United Kingdom Minimally Invasive Biopsy Techniques Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product Offered
    - 7.3.3.2.2. By Technique
    - 7.3.3.2.3. By Circulating Biomarker
    - 7.3.3.2.4. By Application
    - 7.3.3.2.5. By End User
- 7.3.4. Italy Minimally Invasive Biopsy Techniques Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product Offered
    - 7.3.4.2.2. By Technique
    - 7.3.4.2.3. By Circulating Biomarker
    - 7.3.4.2.4. By Application
    - 7.3.4.2.5. By End User
- 7.3.5. Spain Minimally Invasive Biopsy Techniques Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product Offered
    - 7.3.5.2.2. By Technique
    - 7.3.5.2.3. By Circulating Biomarker
    - 7.3.5.2.4. By Application
    - 7.3.5.2.5. By End User

8. Asia Pacific Minimally Invasive Biopsy Techniques Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product Offered
- 8.2.2. By Technique
- 8.2.3. By Circulating Biomarker
- 8.2.4. By Application
- 8.2.5. By End User
- 8.2.6. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Minimally Invasive Biopsy Techniques Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product Offered
    - 8.3.1.2.2. By Technique
    - 8.3.1.2.3. By Circulating Biomarker
    - 8.3.1.2.4. By Application
    - 8.3.1.2.5. By End User
- 8.3.2. India Minimally Invasive Biopsy Techniques Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product Offered
    - 8.3.2.2.2. By Technique
    - 8.3.2.2.3. By Circulating Biomarker
    - 8.3.2.2.4. By Application
    - 8.3.2.2.5. By End User
- 8.3.3. Japan Minimally Invasive Biopsy Techniques Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product Offered
    - 8.3.3.2.2. By Technique
    - 8.3.3.2.3. By Circulating Biomarker
    - 8.3.3.2.4. By Application
    - 8.3.3.2.5. By End User
- 8.3.4. South Korea Minimally Invasive Biopsy Techniques Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product Offered
    - 8.3.4.2.2. By Technique
    - 8.3.4.2.3. By Circulating Biomarker
    - 8.3.4.2.4. By Application
    - 8.3.4.2.5. By End User
- 8.3.5. Australia Minimally Invasive Biopsy Techniques Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product Offered
    - 8.3.5.2.2. By Technique
    - 8.3.5.2.3. By Circulating Biomarker
    - 8.3.5.2.4. By Application
    - 8.3.5.2.5. By End User

9. Middle East & Africa Minimally Invasive Biopsy Techniques Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product Offered
- 9.2.2. By Technique
- 9.2.3. By Circulating Biomarker
- 9.2.4. By Application
- 9.2.5. By End User
- 9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Minimally Invasive Biopsy Techniques Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product Offered
    - 9.3.1.2.2. By Technique
    - 9.3.1.2.3. By Circulating Biomarker
    - 9.3.1.2.4. By Application
    - 9.3.1.2.5. By End User
- 9.3.2. UAE Minimally Invasive Biopsy Techniques Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product Offered
    - 9.3.2.2.2. By Technique
    - 9.3.2.2.3. By Circulating Biomarker
    - 9.3.2.2.4. By Application
    - 9.3.2.2.5. By End User
- 9.3.3. South Africa Minimally Invasive Biopsy Techniques Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product Offered
    - 9.3.3.2.2. By Technique
    - 9.3.3.2.3. By Circulating Biomarker
    - 9.3.3.2.4. By Application
    - 9.3.3.2.5. By End User

10. South America Minimally Invasive Biopsy Techniques Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product Offered
- 10.2.2. By Technique
- 10.2.3. By Circulating Biomarker
- 10.2.4. By Application
- 10.2.5. By End User
- 10.2.6. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Minimally Invasive Biopsy Techniques Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product Offered
    - 10.3.1.2.2. By Technique
    - 10.3.1.2.3. By Circulating Biomarker
    - 10.3.1.2.4. By Application
    - 10.3.1.2.5. By End User
- 10.3.2. Colombia Minimally Invasive Biopsy Techniques Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product Offered
    - 10.3.2.2.2. By Technique
    - 10.3.2.2.3. By Circulating Biomarker
    - 10.3.2.2.4. By Application
    - 10.3.2.2.5. By End User
- 10.3.3. Argentina Minimally Invasive Biopsy Techniques Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product Offered
    - 10.3.3.2.2. By Technique
    - 10.3.3.2.3. By Circulating Biomarker
    - 10.3.3.2.4. By Application
    - 10.3.3.2.5. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Minimally Invasive Biopsy Techniques Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. F. Hoffmann-La Roche AG
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Thermo Fisher Scientific, Inc.
15.3. PerkinElmer Inc.
15.4. QIAGEN NV
15.5. Guardant Health, Inc.
15.6. Veracyte, Inc.
15.7. Myriad Genetics, Inc.
15.8. Biocept, Inc.
15.9. NeoGenomics Laboratories, Inc.
15.10. Adaptive Biotechnologies Corporation